( en | de | ru )

 

Disambiguation of "Hasenclever, Dirk"

Author of the publication

copydeleteadd this publication to your clipboard
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies

, , , , , , , , , , , , , , , , and . Klinische Pädiatrie, 216 (3): 150–156 (2004)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Dirk Hasenclever

Hertha Hasenclever

Max Hasenclever

Christa Hasenclever

Jörg Hasenclever

 

Other publications of authors with the same name

Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF, , , , , , , , , and 3 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 12 (4): 471–477 (2001)Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence, , and . Antiviral therapy, 13 (2): 211–220 (2008)Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group, , , , , , , , , and . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 (3): 580–586 (1994)Are endoscopic antireflux therapies cost-effective compared with laparoscopic fundoplication?, , , , , , and . Endoscopy, 37 (3): 217–222 (2005)The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis, , , , , , , , , and 1 other author(s). Thrombosis and haemostasis, 99 (5): 925–929 (2008)Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , and 3 other author(s). Blood, 104 (3): 634–641 (2004)Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study, , , , , , , , , and 10 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (23): 3680–3686 (2010)High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML), , , , , , , , and . Leukemia, 16 (1): 22–29 (2002)A novel view on stem cell development: analysing the shape of cellular genealogies, , , and . Cell proliferation, 42 (2): 248–263 (2009)Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks, and . Bone marrow transplantation, (1996)